000 01180 a2200313 4500
005 20250517092325.0
264 0 _c20170314
008 201703s 0 0 eng d
022 _a1532-1932
024 7 _a10.1016/j.bpobgyn.2016.03.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBhide, Priya
245 0 0 _aAnti-Müllerian hormone and polycystic ovary syndrome.
_h[electronic resource]
260 _bBest practice & research. Clinical obstetrics & gynaecology
_cNov 2016
300 _a38-45 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnovulation
_xetiology
650 0 4 _aAnti-Mullerian Hormone
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Follicle
_xmetabolism
650 0 4 _aOvarian Hyperstimulation Syndrome
_xetiology
650 0 4 _aOvulation Induction
_xadverse effects
650 0 4 _aPolycystic Ovary Syndrome
_xcomplications
650 0 4 _aRisk Assessment
700 1 _aHomburg, Roy
773 0 _tBest practice & research. Clinical obstetrics & gynaecology
_gvol. 37
_gp. 38-45
856 4 0 _uhttps://doi.org/10.1016/j.bpobgyn.2016.03.004
_zAvailable from publisher's website
999 _c25948605
_d25948605